Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet‐induced obese and leptin‐deficient rodentsJames L. Trevaskis, Jonathan D. Roth, Y. Wang et al.|Diabetes Obesity and Metabolism|2014Cited by 59
Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent modelsJason R. Clapper, Jonathan D. Roth, Jennifer Athanacio et al.|European Journal of Pharmacology|2012Cited by 28
Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodentsJonathan D. Roth, David G. Parkes, Jeffrey C. Hoyt et al.|Diabetes Obesity and Metabolism|2012Cited by 22
Amylin/leptin synergy is absent in extreme obesity and not restored by calorie restriction‐induced weight loss in ratsJames L. Trevaskis, Jonathan D. Roth, Carrie Wittmer et al.|Obesity Science & Practice|2016Cited by 22